ArticlePharmacoEconomics1999
Prescribing at the interface between primary and secondary care in the UK. Towards joint formularies?
Article in PharmacoEconomics, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it.
- [A systematic review of therapy coordination between primary and specialist care].Atencion primaria · 2007Pooled it
- Biosimilar uptake by British local formularies: a cross sectional study.International journal of clinical pharmacy · 2017Article
- Evaluation of angiotensin II receptor blockers for drug formulary using objective scoring analytical tool.Pharmacy practice · 2012Article
- The influence of hospitalisation on drug prescription in primary care--a large-scale follow-up study.European journal of clinical pharmacology · 2007Article
- Insufficient communication about medication use at the interface between hospital and primary care.Quality & safety in health care · 2007Article
- [Induced prescription from reference hospital Universitari Vall d'Hebron to general practitioners].Atencion primaria · 2004Article
- Congruence on medication between patients and physicians involved in patient course.European journal of clinical pharmacology · 2004Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The current divisions in managing prescribing between primary and secondary care in the UK arise from separate budgetary arrangements. These divisions are neither sensible, organisationally efficient nor cost effective. Transition of patients across the interface of primary and secondary care has always been problematic, hindered by poor communication and coordination. Joint formularies would improve overall care and raise awareness of the need to consider overall costs within a unified National Health Service (NHS). There are, however, few examples of successful working of a joint formulary in the UK. It is likely that harmonisation of drug use in hospitals and in primary care will come about because of contracting and commissioning, and that it will largely be led by primary care, through the developing primary care groups (PCGs). Local decisions around availability and use of drug therapies will increasingly be superseded by the national decisions emanating from the newly formed National Institute for Clinical Effectiveness.
Indexed as
Identifiers
10537961What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.